Head and Neck Cancer

Course Description

Head and neck cancer is an important potential indication for many drug development teams and this course has been developed specifically for pharmaceutical industry personnel. It is ideal for individuals who are new to the therapy area or who have a particular interest or involvement in the subject. Equally, those who already have a basic knowledge of head and neck cancer will find the clinical perspective provided by Healthcare’s expert faculty enlightening and beneficial.

Delegates will hear a real life view for the rationale behind management strategies in this challenging patient group. Future trends will be reviewed as well as the most promising therapies and current clinical trials.

Healthcare’s courses are highly interactive and throughout the programme delegates will have the opportunity to ask questions and engage in discussion with our faculty.

Topics to be covered include:

• What is head and neck cancer?
• Who gets head and neck cancer?
• Patterns of patient presentation
• Investigation, diagnosis and prognosis
• Management strategies
• Matching treatment to the clinical problem
• Unanswered questions and clinical trials